Market Overview

CVS The Likely Winner If Anthem Is Moving On From Express Scripts

CVS The Likely Winner If Anthem Is Moving On From Express Scripts

Express Scripts Holding Company (NASDAQ: ESRX)'s earnings report was dominated by a concerning disclosure that it expects lose its largest customer, Anthem Inc (NYSE: ANTM). Anthem alleged that it is being overcharged by billions of dollars and is not expected to renew the contract, which expires in 2019.

In a research report following Express Scripts' earnings release, Leerink's David Larsen acknowledged it is "unusual" that Anthem didn't publish a press release in which it acknowledged the contract will terminate. Nevertheless, the analyst is confident that the relationship will, in fact, end on December 31, 2019.

Larsen noted that throughout 2016, Anthem contributed $2.2 billion of EBITDA for Express Scripts while Coventry & Catamaran contributed $222 million. As such, $2.5 billion, or 34 percent of Express Scripts' EBITDA will move out of its overall portfolio. In fact, Larsen argued that the impact of the loss of business is "larger than many investors expected."

Good News For CVS Or Prime

Anthem will likely be moving away from Express Scripts' platform and there are only two companies that are large enough to support Anthem's business: CVS Health Corp (NYSE: CVS) or Prime Therapeutics, the recently combined specialty and mail businesses of Prime and Walgreens Boots Alliance Inc (NASDAQ: WBA).

The analyst added that Prime Therapeutics has a "preferred retail relationship" and if it were to win the Anthem contract, much of the incremental volumes will benefit Walgreens and AmerisourceBergen Corp. (NYSE: ABC), a supplier to Walgreens. Specifically, incremental volumes from AmerisourceBergen would be from more retail Rx flowing through to Walgreens along with generic products, if Prime participates in WBAD.

Bottom line, even though Express Scripts' earnings report was "good" the Anthem announcement is the main takeaway.

Related Links:

Express Scripts Downgraded On Fear It Could Lose Anthem Contract

5 Concerns Express Scripts Confirmed With Its Announcement It Will Likely Lose Anthem Business
Image Credit: By hattiesburgmemory (CVS Pharmacy Uploaded by AlbertHerring) [CC BY 2.0 (], via Wikimedia Commons

Latest Ratings for ABC

Jun 2019MaintainsBuy
Apr 2019DowngradesBuyUnderperform
Apr 2019DowngradesOutperformIn-Line

View More Analyst Ratings for ABC
View the Latest Analyst Ratings

Posted-In: Analyst Color Biotech M&A News Health Care Rumors Analyst Ratings General Best of Benzinga


Related Articles (ABC + ANTM)

View Comments and Join the Discussion!

Latest Ratings

WUBABOCOM InternationalDowngrades
DLTROTR GlobalUpgrades
ARCCCompass PointDowngrades
GTYHCitiInitiates Coverage On7.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Fuel On The Fire: Trump Hikes Canadian Timber Tariffs In Retaliation For Milk Duty

8 Technical Levels From Tuesday's PreMarket Prep